MedTrace Logo

The Effects of Intranasal and Oral Administration of Oxytocin on Responses to Emotional Scenes

NCT05532501 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2022-09-08

No results posted yet for this study

Summary

The study will investigate whether oxytocin administered either intranasally or orally (lingual) (24 international units, IU) can differentially modulate men's neural and behavioral responses to emotional scenes using an implicit emotional paradigm.

Conditions

  • Healthy

Interventions

DRUG

Oral Oxytocin

Administer oxytocin (24 IU) orally, 6 individual 0.1 ml puffs (4 IU/0.1ml) on the tongue (lingual), one every 30 seconds

DRUG

Intranasal Oxytocin

Administer oxytocin (24 IU) intranasally, 6 individual 0.1 ml puffs (4 IU/0.1ml), three puffs per nostril one every 30 seconds

DRUG

Oral placebo

Administer placebo orally, 6 individual 0.1 ml puffs on the tongue (lingual), one every 30 seconds.

DRUG

Intranasal placebo

Administer placebo intranasally, 6 individual 0.1 ml puffs, three puffs per nostril one every 30 seconds

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Keith M Kendrick, PhD · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-20
Primary Completion
2022-12-20
Completion
2023-02-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05532501 on ClinicalTrials.gov